Philipp Suter
Dundee, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Improvement of Severe Volume Dependent Airway Closure With Tezepelumab: A Case Report.
Journal: Clinical case reports
Published: July 10, 2026
Improved peripheral airway reactance is associated with clinical remission following biologic therapy in severe asthma.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: June 11, 2026
Comparison of artificial intelligence and multidisciplinary team assessment for evaluating biologic decisions in severe uncontrolled asthma.
Journal: The journal of allergy and clinical immunology. In practice
Published: May 26, 2026
Relationships Between Bronchodilator Reversibility and Mannitol Airway Hyperresponsiveness in Severe Asthma.
Journal: Clinical and translational allergy
Published: April 13, 2026
Impact of dupilumab on Sino-Nasal Outcome Test-22 (SNOT-22) domains: Focus on the ear.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: March 30, 2026
Delayed Diagnosis of Cystic Fibrosis and Nontuberculous Mycobacterial Infection in Refractory CRSwNP.
Journal: Respirology case reports
Published: March 17, 2026
Impact of Biologics on Oscillometry Defined Small Airway Dysfunction in Uncontrolled Asthma.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: March 05, 2026
Are Phenotypic Baseline Characteristics Related to Abolition of AHR After Benralizumab and Dupilumab?
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: February 09, 2026
Oscillometry may be used to detect bronchodilator reversibility in asthma patients with preserved spirometry.
Journal: The journal of allergy and clinical immunology. In practice
Published: February 03, 2026
BAL lymphocytosis as a predictive marker for drug response and long-term outcome in fibrotic ILD: systematic review.
Journal: BMJ open respiratory research
Published: December 16, 2025
Bucher indirect treatment comparison of phase 3 trials with dupilumab and tezepelumab in chronic rhinosinusitis with nasal polyps.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: December 16, 2025
Last Updated: 09/26/2026